Evaluation of oestrogen and progesterone receptors, and c-erbB-2 in carcinoma of the breast in Trinidadian women

West Indian Medical Journal

Volumn 51, Issue 1, 2002, Pages 4-9

  Rao, A V C ^a   Mohammed, W A ^a   Ragoonanan, C ^a   Omo Igbinomwanhia, N E ^a  

^a UNIVERSITY OF THE WEST INDIES   (Trinidad and Tobago)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; GROWTH FACTOR RECEPTOR; ONCOPROTEIN; PARAFFIN; PROGESTERONE RECEPTOR; STEROID RECEPTOR; TUMOR MARKER;

ADULT; ARTICLE; BREAST CARCINOMA; CANCER ADJUVANT THERAPY; CANCER GRADING; CARCINOMA IN SITU; CONTROLLED STUDY; CORRELATION ANALYSIS; ETHNIC GROUP; FEMALE; GENDER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MUCINOUS CARCINOMA; ONCOGENE C ERB; PAGET NIPPLE DISEASE; PROGNOSIS; TISSUE SECTION; TISSUE TYPING; TRINIDAD AND TOBAGO; TUMOR VOLUME;

ADULT; AGED; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; TRINIDAD AND TOBAGO; TUMOR MARKERS, BIOLOGICAL;

EID: 0036265932     PISSN: 00433144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. The predictive value of estrogen and progesterone receptors' concentrations on the clinical behavior of breast cancer in women. Clinical correlation on 547 patients
2. Steroid hormone receptors and their clinical significance in cancer
3. Steroid receptors in breast cancer
4. What can be now expected of the determination of estrogen and progesterone receptors in the treatment of breast cancers
5. Immunocytochemical localization of estrogen and progesterone receptor and prognosis in human primary breast cancer
6. C-erbB-2 overexpression decreases the benefit of adjuvant tamoxifen in early-stage breast cancer without axillary lymph node metastases
7. Determination of Erb-B2 protein in breast cancer tissues by different methods. Relationships with other biological parameters
8. Immunohistochemical analysis of overexpression of c-erbB-2 protein in node-positive breast carcinoma
9. The prognostic value of c-erbB-2 in primary breast carcinomas: A study on 942 cases
10. HER-2/neu protein expression in breast cancer evaluated by immunohistochemistry. A study of interlaboratory agreement
11. Primary chemotherapy in breast invasive carcinoma: Predictive value of the immunohistochemical detection of hormonal receptors, p53, c-erbB-2, MiB1, pS2 and GSTpi
12. Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory treatment
13. Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease
14. Prognostic factors and treatment decisions in axillary-node negative breast cancer
15. Estrogen receptor versus nuclear grade as prognostic factors in axillary node negative breast cancer
16. Relation of tumor size, lymph node status and survival in 24, 740 breast cancer cases
17. Prognosis and breast cancer. Recognition of lethal and favorable prognostic types
18. Implication of extracapsular nodal metastases for treatment and prognosis of breast cancer
19. College of American Pathologists Conference XXVI on clinical relevance of prognostic markers in solid tumors
20. Immunohistochemical tumor markers in infiltrating ductal breast carcinoma
21. Breast carcinoma: Evaluation of hormone receptors and pS2, erbB-2, P-glycoprotein, and Ki-67 Markers
22. Comparison of immunohistochemical and biochemical measurement of steroid receptors in primary breast cancer: Evaluation of discordant findings
23. P34cdc2 in invasive breast cancer: Relationship to DNA content, Ki67 index and c-erbB-2 expression
24. Oestrogen receptor, progesterone receptor, pS2, ERD5, HSP27 and cathepsin D in invasive ductal breast carcinomas
25. Tumor biologic factors and breast cancer prognosis among white, Hispanic and black women in the United States
26. Erb-B2 oncoprotein overexpression in breast carcinoma: Inverse correlation with biochemically- and immunohistochemically-determined hormone receptors
27. Hormonal receptors, cell proliferation fraction (Ki-67) and c-erbB-2 amplification in breast cancer. Relationship between differentiation degree and axillary lymph node metastases
28. HER-2 amplification, steroid receptors and epidermal growth factor receptor in primary breast cancer
29. Prognostic significance of c-erbB-2 and hormone receptors' status in human benign and malignant breast lesions
30. Immunohistochemical detection of HER-2/neu in patients with axillary lymph node negative breast carcinoma. A study of epidemiologic risk factors, histologic features, and prognosis
31. Relationship between c-erbB-2 oncoprotein, epidermal growth factor receptor, and estrogen receptor expression in patients with ductal breast carcinoma. Association with tumor phenotypes
32. Prognostic and predictive factors in breast cancer by immunohistochemical analysis